These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7774053)
61. T cell and non-T cell compartments can independently determine resistance to Leishmania major. Shankar AH; Titus RG J Exp Med; 1995 Mar; 181(3):845-55. PubMed ID: 7869047 [TBL] [Abstract][Full Text] [Related]
62. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Gessner A; Blum H; Röllinghoff M Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519 [TBL] [Abstract][Full Text] [Related]
63. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. Himmelrich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA; Launois P J Immunol; 1998 Dec; 161(11):6156-63. PubMed ID: 9834101 [TBL] [Abstract][Full Text] [Related]
64. Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-l-cysteine. Rocha-Vieira E; Ferreira E; Vianna P; De Faria DR; Gaze ST; Dutra WO; Gollob KJ Immunology; 2003 Mar; 108(3):401-8. PubMed ID: 12603607 [TBL] [Abstract][Full Text] [Related]
65. Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice. Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D Korean J Parasitol; 2007 Jun; 45(2):103-9. PubMed ID: 17570972 [TBL] [Abstract][Full Text] [Related]
66. Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection. Hondowicz B; Scott P Infect Immun; 2002 Feb; 70(2):498-503. PubMed ID: 11796575 [TBL] [Abstract][Full Text] [Related]
68. Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major. Müller I; Kropf P; Louis JA; Milon G Infect Immun; 1994 Jun; 62(6):2575-81. PubMed ID: 8188380 [TBL] [Abstract][Full Text] [Related]
69. In vivo protective effect of the lectin from Canavalia brasiliensis on BALB/c mice infected by Leishmania amazonensis. Barral-Netto M; Von Sohsten RL; Teixeira M; dos Santos WL; Pompeu ML; Moreira RA; Oliveira JT; Cavada BS; Falcoff E; Barral A Acta Trop; 1996 Feb; 60(4):237-50. PubMed ID: 8659323 [TBL] [Abstract][Full Text] [Related]
70. Development and Characterization of an Avirulent Jha MK; Sarode AY; Bodhale N; Mukherjee D; Pandey SP; Srivastava N; Rub A; Silvestre R; Sarkar A; Saha B J Immunol; 2020 May; 204(10):2734-2753. PubMed ID: 32245818 [No Abstract] [Full Text] [Related]
71. 2,3,7,8-tetrachlorodibenzo-p-dioxin slows the progression of experimental cutaneous Leishmaniasis in susceptible BALB/c and SCID mice. DeKrey GK; Teagarden RE; Lenberg JL; Titus RG PLoS One; 2013; 8(10):e76259. PubMed ID: 24098456 [TBL] [Abstract][Full Text] [Related]
72. Influence of microbiota in experimental cutaneous leishmaniasis in Swiss mice. de Oliveira MR; Tafuri WL; Nicoli JR; Vieira EC; Melo MN; Vieira LQ Rev Inst Med Trop Sao Paulo; 1999; 41(2):87-94. PubMed ID: 10413955 [TBL] [Abstract][Full Text] [Related]
73. The role of polymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis. Lima GM; Vallochi AL; Silva UR; Bevilacqua EM; Kiffer MM; Abrahamsohn IA Immunol Lett; 1998 Dec; 64(2-3):145-51. PubMed ID: 9870666 [TBL] [Abstract][Full Text] [Related]
75. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. Beil WJ; Meinardus-Hager G; Neugebauer DC; Sorg C J Leukoc Biol; 1992 Aug; 52(2):135-42. PubMed ID: 1506767 [TBL] [Abstract][Full Text] [Related]
76. Role of interferon-induced GTPases in leishmaniasis. Lipoldová M; Sohrabi Y PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010093. PubMed ID: 35085246 [No Abstract] [Full Text] [Related]
78. Kinetics of an experimental inflammatory reaction induced by Leishmania major during the implantation of paraffin tablets in mice. Tafuri WL; Melo MN; Paiva MC; Mosser DM; Tafuri WL Virchows Arch; 2000 Oct; 437(4):429-35. PubMed ID: 11097369 [TBL] [Abstract][Full Text] [Related]
79. Leishmania major infection in BALB/c mice: protection or exacerbation by treatment with different doses of BCG. Stefani MM; Müller I; Louis J Res Immunol; 1993 May; 144(4):233-43. PubMed ID: 8378590 [TBL] [Abstract][Full Text] [Related]
80. Histopathology of Leishmania major infection: revisiting L. major histopathology in the ear dermis infection model. Cangussú SD; Souza CC; Campos CF; Vieira LQ; Afonso LC; Arantes RM Mem Inst Oswaldo Cruz; 2009 Sep; 104(6):918-22. PubMed ID: 19876567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]